Mode of mutagenic action of methylnitrosocyanamide, a potent carcinogen. 1978

K Hidaka, and M Ishizawa, and N Otsuji, and H Endo

A potent carcinogen, methylnitrosocyanamide was used to induce revertants in a strain of Escherichia coli carrying an amber mutation in a gene for tryptophan (trp) biosynthesis and an ochre mutation in a gene for alkaline phosphatase biosynthesis. Trp+ revertants were purified and classified into seven categories based on their ability to support the growth of particular nonsense mutants of phage lambda and on their content of alkaline phosphatase. About 90% of the Trp+ revertants induced by methylnitrosocyanamide were due to mutations in suppressor genes, and 85% of the suppressor mutations occurred in gene supE. Intragenic reversion cannot occur by a GC leads to AT base substitution mutation, whereas this is the obligate mode of mutation in gene supE. We conclude that methylnitrosocyanamide preferentially induces GC leads to AT transition mutations but that other base substitution mutations are also induced at about 10% of this frequency. N-Methyl-N-nitrosourea and, particularly, N-methyl-N'-nitro-N-nitrosoguanidine also preferentially induce GC leads to AT transition mutations.

UI MeSH Term Description Entries
D008769 Methylnitronitrosoguanidine A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. Methylnitrosonitroguanidine,Nitrosomethylnitroguanidine,Nitrosonitromethylguanidine,MNNG,N-Methyl-N'-nitro-N-nitrosoguanidine,N Methyl N' nitro N nitrosoguanidine
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D003484 Cyanamide A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. Calcium Carbimide,Calcium Cyanamide,Citrated Calcium Cyanamide,Abstem,Carbimide,Colme,Cyanamide, Calcium (1:1) Salt,Cyanamide, Calcium (2:1) Salt,Cyanamide, Calcium Salt,Temposil,Calcium Cyanamide, Citrated,Calcium Salt Cyanamide,Carbimide, Calcium,Cyanamide, Calcium,Cyanamide, Citrated Calcium
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013489 Suppression, Genetic Mutation process that restores the wild-type PHENOTYPE in an organism possessing a mutationally altered GENOTYPE. The second "suppressor" mutation may be on a different gene, on the same gene but located at a distance from the site of the primary mutation, or in extrachromosomal genes (EXTRACHROMOSOMAL INHERITANCE). Suppressor Mutation,Genetic Suppression,Genetic Suppressions,Mutation, Suppressor,Mutations, Suppressor,Suppressions, Genetic,Suppressor Mutations

Related Publications

K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
April 1967, Biochemical pharmacology,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
July 1978, Experientia,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
October 1949, Science (New York, N.Y.),
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
August 1967, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
February 2000, Endocrine reviews,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
September 2023, Chemico-biological interactions,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
August 1975, Mutation research,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
September 1968, Die Naturwissenschaften,
K Hidaka, and M Ishizawa, and N Otsuji, and H Endo
January 2012, Mutation research. Reviews in mutation research,
Copied contents to your clipboard!